Strategy Boosts Cash Reserve to $2.2 Billion via Stock Sales

The assessment is "likely_true" with high confidence based on strong, consistent evidence from multiple high-authority sources. One source, with the highest relevance and authority, directly and explicitly confirms all parts of the statement. It states that 'Strategy' (MicroStrategy) sold '$747.8 million in common stock' to increase its cash reserve to 'about $2.2 billion,' and cites a primary SEC filing as its source, which lends it significant credibility.This core evidence is corroborated by three other reputable financial news sources. These sources independently confirm that a company named 'Strategy' has a cash reserve of approximately $2.2 billion. While they do not specify that the funds came from stock sales, their reporting on the company and the cash reserve amount is entirely consistent with the most detailed source. There are no contradictions among the relevant sources.The majority of the provided sources are irrelevant to the claim. They discuss different companies (e.g., 'Strategy Asset Managers, L.L.C.', 'MiniMed Group Inc.', 'NMG'), different financial amounts, or use the word 'strategy' in a generic context rather than as a company name. These irrelevant sources do not provide any conflicting evidence and therefore do not weaken the conclusion. The convergence of information from the relevant, high-quality sources makes the original statement highly probable.